search
Back to results

The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients

Primary Purpose

Peritoneal Dialysis Complication, Hypoalbuminemia, Malnutrition

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
increased protein intake via natural foods
increase protein intake via protein supplements
Sponsored by
Kaiser Permanente
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peritoneal Dialysis Complication focused on measuring peritoneal dialysis, albumin, end stage renal disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age over 18 years
  • Initiation of peritoneal dialysis for at least a one-month time period, with the expectation to stay on peritoneal dialysis for the next 3 months
  • Independence with all activities of daily living (especially being able to cook)

Exclusion Criteria:

  • Age under 18 years
  • Expectation of termination of peritoneal dialysis within 3 months of entering the study
  • Life expectancy less than three months
  • Termination of life or peritoneal dialysis during the study period
  • Patient refusal

Sites / Locations

  • Kaiser Permanente Riverside Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Supplement Group

Natural Food Group

Arm Description

The protein supplement group was instructed by their dietician in how many protein supplements to consume in addition to their natural food intake in order to reach their goal protein intake.

The Natural food group was instructed by their dietician in how much additional protein rich foods to eat in order to reach their goal protein intake.

Outcomes

Primary Outcome Measures

Serum Albumin Levels
serum levels of albumin

Secondary Outcome Measures

Serum Phosphorus levels
measured monthly
Goal protein intake
Via food diaries the total protein intake was calculated
Serum albumin levels
throughout the study

Full Information

First Posted
May 22, 2018
Last Updated
June 22, 2018
Sponsor
Kaiser Permanente
search

1. Study Identification

Unique Protocol Identification Number
NCT03569410
Brief Title
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients
Official Title
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients An Open-label Prospective Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
October 2016 (Actual)
Primary Completion Date
February 2017 (Actual)
Study Completion Date
February 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Permanente

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is a prospective open label clinical trial comparing serum albumin levels and total protein intake in the peritoneal dialysis patient population. A total of 60 patients were enrolled, 16 chose to be in the natural food group and 44 in the supplement group. 4 were lost to follow-up in the supplement group leading to an n of 40. Both groups were educated by dietitians on how to increase their protein intake to a goal of 1.4g/kg/day. The groups were followed for 3 months with protein intake calculated according to the patient's food diaries. Patient demographics and characteristics were compared in both groups.
Detailed Description
This is a prospective open label clinical trial comparing serum albumin levels and total protein intake in the peritoneal dialysis patient population. Two treatment groups were established: a natural food group who was instructed by their dietician in how to reach their goal protein intake through purely increasing the consumption of natural foods rich in protein versus a protein supplement group who was instructed by their dietician in how many protein supplements to consume in addition to their natural food intake in order to reach their goal protein intake. To increase compliance, patients were allowed to choose which treatment group they wanted to participate in. Patients, however, were not allowed to change groups during the study. At the initiation of the study patients were asked to record food diaries so the dietician can calculate their baseline protein intake. Each patient had an assigned dietician who met with the patient monthly. The food diaries were collected during their monthly visits. Patients were also randomly called and asked to give their food intake during the last 24 hours in order to minimize recall bias. Each month the participant's dietician calculated their protein intake deficit and educated the patient on how to increase their protein intake to reach their goal of 1.4g/kg/day. The recommended protein intake for peritoneal dialysis patients is between 1.2 to 1.5 g/kg/day. Therefore, a goal of 1.4g/kg/day was set, which is at the higher end of the goal range in order to ensure an adequately high protein intake. The patient's serum albumin levels, phosphate levels, kt/v, and total protein intake were recorded at baseline, month 1 (M1), month 2 (M2), and month 3 (M3). Furthermore, all major comorbidities in each patient were recorded and compared. Data was extracted from the electronical medical record system and entered into a password protected file. This data was then analyzed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peritoneal Dialysis Complication, Hypoalbuminemia, Malnutrition
Keywords
peritoneal dialysis, albumin, end stage renal disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Open-label prospective clinical trial.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Supplement Group
Arm Type
Active Comparator
Arm Description
The protein supplement group was instructed by their dietician in how many protein supplements to consume in addition to their natural food intake in order to reach their goal protein intake.
Arm Title
Natural Food Group
Arm Type
Experimental
Arm Description
The Natural food group was instructed by their dietician in how much additional protein rich foods to eat in order to reach their goal protein intake.
Intervention Type
Behavioral
Intervention Name(s)
increased protein intake via natural foods
Intervention Description
Patients had to eat 1.4g/kg/day of natural protein.
Intervention Type
Behavioral
Intervention Name(s)
increase protein intake via protein supplements
Intervention Description
Patients ate enough protein supplements in addition to their regular diet to reach eat 1.4g/kg/day of protein intake.
Primary Outcome Measure Information:
Title
Serum Albumin Levels
Description
serum levels of albumin
Time Frame
After three months of intervention.
Secondary Outcome Measure Information:
Title
Serum Phosphorus levels
Description
measured monthly
Time Frame
At Month 0, 1, 2, and 3
Title
Goal protein intake
Description
Via food diaries the total protein intake was calculated
Time Frame
At Month 0, 1, 2, and 3
Title
Serum albumin levels
Description
throughout the study
Time Frame
At Month 0, 1, 2, and 3

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age over 18 years Initiation of peritoneal dialysis for at least a one-month time period, with the expectation to stay on peritoneal dialysis for the next 3 months Independence with all activities of daily living (especially being able to cook) Exclusion Criteria: Age under 18 years Expectation of termination of peritoneal dialysis within 3 months of entering the study Life expectancy less than three months Termination of life or peritoneal dialysis during the study period Patient refusal
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susan Sun, MD
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaiser Permanente Riverside Medical Center
City
Riverside
State/Province
California
ZIP/Postal Code
92505
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23580797
Citation
Jeloka TK, Dharmatti G, Jamdade T, Pandit M. Are oral protein supplements helpful in the management of malnutrition in dialysis patients? Indian J Nephrol. 2013 Jan;23(1):1-4. doi: 10.4103/0971-4065.107185.
Results Reference
background
PubMed Identifier
16697495
Citation
Cano N, Fiaccadori E, Tesinsky P, Toigo G, Druml W; DGEM (German Society for Nutritional Medicine); Kuhlmann M, Mann H, Horl WH; ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN Guidelines on Enteral Nutrition: Adult renal failure. Clin Nutr. 2006 Apr;25(2):295-310. doi: 10.1016/j.clnu.2006.01.023. Epub 2006 May 12.
Results Reference
background
PubMed Identifier
10895784
Citation
Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000 Jun;35(6 Suppl 2):S17-S104. doi: 10.1053/ajkd.2000.v35.aajkd03517. No abstract available. Erratum In: Am J Kidney Dis 2001 Oct;38(4):917.
Results Reference
background

Learn more about this trial

The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients

We'll reach out to this number within 24 hrs